Skip to main content
Have a personal or library account? Click to login
Comparative Analysis of Copper and Zinc Levels in Hepatitis C, Oncology and Healthy Group Cover

Comparative Analysis of Copper and Zinc Levels in Hepatitis C, Oncology and Healthy Group

Open Access
|Jun 2026

References

  1. Ivanova I, Atanasova B, Kostadinova A, et al. A serum copper and zinc In a representative sample of Bulgarian population. Acta Med Bulg, 2016, 43(2):21-31.
  2. Ferreira R, William G. Disorders of metal metabolism. Transl Sci Rare Dis, 2017, 2(3-4):101-139.
  3. Mlchalczyk K, Cymbaluk-Ptoska A. The role of zinc and copper In gynecological malignancies. Nutrients, 2020,12(12):3732.
  4. Strashimirov D, Milanov V, Yordanova R, et al. Patients with HIV and tuberculosis coinfection, treated in the Specialized Hospital for Infectious and Parasitic Diseases in Sofia, Bulgaria, for the period 2017-2019. Acta Med Bulg, 2024, 51(Suppl 2): 13-18.
  5. Gupta S, Read A, Shackel A, et al. The role of micronutrients in the infection and subsequent response to hepatitis C virus. Cells, 2019, 8(6):603.
  6. Gulubova M, Chonov D, Ignatova M, et al. New approach in understanding colorectal cancer immunosuppression and immunotherapy-based strategies in the treatment of microsatellite stable colorectal cancer. Acta Med Bulg, 2024,51 (2):65-76.
  7. Bhatnagar K, Raju S, Patki N, et al. Targeting mineral metabolism in cancer: insights into signaling pathways and therapeutic strategies. Semin Cancer Biol, 2025, 112:1-19.
  8. Zfowocka-Perfowska E, Baszuk P, Marciniak W, et al. Blood and serum copper and zinc levels and 10-year survival of patients after kidney cancer diagnosis. Nutrients, 2025, 17(6):944.
  9. Popov T, Giragosyan S, Petkova V, et al. Regulatory rale of microRNAs in tumor angiogenesis. Acta Med Bulg, 2020, 47:67-72.
  10. Mayo Rochester. Interpretive Handbook. Rochester, Mayo Clinic, 2022.
  11. Malavolta M, Piacenza F, Basso A, etal. Serum copper to zinc ratio: relationship with aging and health status. Mech Ageing Dev, 2015, 151:93-100.
  12. Brewer J, Merajver S. Cancer therapy with tetrathiomolyb- date: antiangiogenesis by lowering body copper - a review. Integr Cancer Ther, 2002,1(4):327-339.
  13. Escobedo-Monge M, Barrado E, Parodi-Roman J, et al. Copper/zinc ratio in childhood and adolescence: a review. Metabolites, 2023, 13(1):82.
  14. Margalioth E, Schenker J, Chevion M. Copper and zinc levels in normal and malignant tissues. Cancer, 1983,52(5):868-872.
  15. Costello L, Franklin R. Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity. Expert Rev Anticancer Ther, 2011,12(1):121-128.
  16. Heuberger D, Harankhedkar S, et al. High-affinity Cu(l) chelator PSP-2 as potential anti-angiogenic agent. Sci Rep, 2019,9(1):1-10.
  17. Nasulewicz-Goldeman A, Mazur A, Opolski A. Role of copper in tumour angiogenesis-clinical implications. J Trace Elem Med Biol, 2004, 18(1):1-8.
  18. Kong R, Sun G. Targeting copper metabolism: a promising strategy for cancer treatment. Front Pharmacol, 2023,14:1-12.
  19. Cai L, Li X, Song Y, Cherian M. Essentiality, toxicology and chelation therapy of zinc and copper. Curr Med Chem, 2005, 12(23):2753-2763.
  20. Wang J, Zhao H, Xu Z, Cheng X. Zinc dysregulation in cancers and its potential as a therapeutic target. Cancer Biol Med, 2020, 17(3):612-625.
  21. Antoniades V, Sioga A, Dietrich E, et al. Is copper chelation an effective anti-angiogenic strategy for cancer treatment? Med Hypotheses, 2013, 81(6):1159-1163.
  22. Tamai Y, Iwasa M, Eguchi A, et al. Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma. PLoS One, 2020,15(8):1-12.
  23. Martínez-Peinado M, Rueda-Robles A, Nogueras-López F, et al. Serum zinc and copper concentrations and ratios in cirrhotic patients: correlation with severity index. Nutr Hosp, 2018, 35(3):627-632.
  24. Rodriguez-Moreno F, Gonzdlez-Reimers E, Santolaria-Fernandez F, et al. Zinc, copper, manganese, and iron in chronic alcoholic liver disease. Alcohol, 1997,14(1):39-44.
DOI: https://doi.org/10.2478/amb-2026-0054 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Language: English
Page range: 16 - 21
Submitted on: Nov 15, 2025
Accepted on: Dec 8, 2025
Published on: Jun 16, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 K. Papochiev, P. Trifonov, D. Todovichin, I. Ivanova, P. Milanova-Krasteva, Z. Krastev, published by Medical University - Sofia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.